Archive for the ‘Scientist’ Category

Top Scientists Conduct Clinical Trials on Elysium Health Product

Wednesday, March 21st, 2018

Elysium Health works together with renowned clinicians and scientists from the world’s leading  institutions and universities. The goal of the company is to translate advances in science and technology to create clinically-validated health products that work..

The Founder

The co-founder of the Elysium Health Is Dr. Leonard Guarente. Guarente has conducted significant research on the molecular and genetic causes of aging.In addition to being the chief scientist of Elysium Health, he is also the director of the Paul F. Glenn Center for Biology of Aging Research at MIT.

A Long Path to This Point

The road to producing what would eventually be called “Basis,” Elysium Health first supplement, was not a short one. Basis is the culmination of more than 25 years of aging research and is a clinically validated supplement designed to support health at the cellular level.

The Results of the Studies

In 2016, Elysium Health conducted a clinical trial on Basis to ensure its safety and effectiveness. The participants in the trial were divided into three groups: a group that received the daily recommended dose (2 capsules), a group that received double the daily dose, and a group that received a placebo. In participants who took the daily recommended dose of Basis, NAD+ levels   increased by an average of 40 percent.

Purchasing Basis Today

Anyone who wants to purchase Basis today can do so via the Elysium Health website. Once there, you will notice that the supplement is available in  individual bottles for $60 or as a subscription. The price of a month-to-month plan is $50. However, you can also purchase a six-month subscription for $270 ($45 per month) or a one-year plan for $480 ($40 per month).

Seeking success in the fight against cancer

Saturday, March 11th, 2017


There was a time when it was thought that HIV would be the menace of the 21st century, then, scientists found ways to manage it and suppress the infection, even before cancer. Today, cancer is still one of the leading causes of death and the fact that a new type of cancer seems to get discovered every few days does not make things any better. There are many scientists who have dedicated their lives towards making sure that cancer is managed within the century. One of these scientists is Clay Siegall. Twenty years ago, he started a company by the name of Seattle Genetics hoping that he could get a cure for the problem. Two decades later, he has achieved quite a commendable level of success in what he set out to do.

Clay Siegall had worked in the biotechnology sector for very many years before he started his own company. He had always been passionate about getting treatments and therapies that could help with the treatment of cancer. When he started Seattle Genetics, he put together a team of the people he thought were the best suited to help with the laboratory research. The success of the team was realized when their first treatment for the menace was approved by the FDA. Currently, the medicine is on sale in many countries and the sales are predicted to rise to new levels this year. The success of the company is also the reason it has been listed on NASDAQ, and the company is still trying many new and better treatments for different types of lymphomas.

The sales of the first drug that he has approved hit the quarter of a million dollars mark last year and the company hopes that this year, they will make even better sales. The drug is now retailing in more than 60 countries which shows how effective many medical practitioners around the world have found it. The long term goal of the company is making sure that all the other 12 treatments that are still in the clinical stage get approved and that they achieve even better results in the treatment of cancer.